Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,835,129
  • Shares Outstanding, K 49,228
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 580 M
  • EBITDA $ 1,149 M
  • 60-Month Beta 1.64
  • Price/Sales 2.02
  • Price/Cash Flow 7.52
  • Price/Book 2.56

Options Overview Details

View History
  • Implied Volatility 53.84% (+3.13%)
  • Historical Volatility 49.12%
  • IV Percentile 79%
  • IV Rank 39.93%
  • IV High 86.39% on 04/11/25
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 19) 12.24 (7.69%)
  • Put/Call Vol Ratio 4.54
  • Today's Volume 72
  • Volume Avg (30-Day) 463
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 4,373
  • Open Int (30-Day) 11,693
  • Expected Range 146.92 to 171.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 2.01
  • Number of Estimates 8
  • High Estimate 2.43
  • Low Estimate 1.91
  • Prior Year 2.34
  • Growth Rate Est. (year over year) -14.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.63 +6.37%
on 03/18/26
182.65 -12.86%
on 03/05/26
-19.33 (-10.83%)
since 02/27/26
3-Month
146.33 +8.77%
on 02/18/26
228.88 -30.46%
on 01/13/26
-44.50 (-21.85%)
since 12/26/25
52-Week
91.86 +73.26%
on 04/11/25
228.88 -30.46%
on 01/13/26
+1.10 (+0.70%)
since 03/27/25

Most Recent Stories

More News
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know

ILMN : 117.67 (-5.41%)
EVH : 2.21 (-7.14%)
RGEN : 110.12 (-3.76%)
CRL : 159.16 (-3.62%)
RDNT : 56.15 (-5.49%)
1 Value Stock on Our Buy List and 2 We Turn Down

1 Value Stock on Our Buy List and 2 We Turn Down

MU : 357.22 (+0.50%)
JLL : 292.93 (-2.50%)
CRL : 159.16 (-3.62%)
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

While Charles River Laboratories has underperformed its sector peers recently, analysts remain moderately optimistic about the stock’s prospects.

XLV : 143.26 (-1.70%)
CRL : 159.16 (-3.62%)
IQV : 163.85 (-3.28%)
3 Reasons CRL is Risky and 1 Stock to Buy Instead

3 Reasons CRL is Risky and 1 Stock to Buy Instead

CRL : 159.16 (-3.62%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Pack

CRL : 159.16 (-3.62%)
Charles River Laboratories to Present at TD Cowen and Barclays Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: TD Cowen 46 th...

CRL : 159.16 (-3.62%)
Charles River Laboratories Provides Update on Planned Divestitures

– Announces Signing of Definitive Agreements to Divest the CDMO and Cell Solutions Businesses and Certain European Discovery Services Assets – – Updates 2026 Financial...

CRL : 159.16 (-3.62%)
Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know

Integra LifeSciences, Enovis, BrightSpring Health Services, IQVIA, and Charles River Laboratories Shares Plummet, What You Need To Know

ENOV : 21.82 (-6.63%)
IART : 9.20 (-1.92%)
BTSG : 42.33 (-1.17%)
CRL : 159.16 (-3.62%)
IQV : 163.85 (-3.28%)
What Are Wall Street Analysts' Target Price for Charles River Laboratories Stock?

Charles River Laboratories has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

XLV : 143.26 (-1.70%)
$SPX : 6,368.85 (-1.67%)
CRL : 159.16 (-3.62%)
CRL Q4 Deep Dive: Flat Sales and Margin Pressures as Biotech Demand Recovers

CRL Q4 Deep Dive: Flat Sales and Margin Pressures as Biotech Demand Recovers

CRL : 159.16 (-3.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 174.44
2nd Resistance Point 169.02
1st Resistance Point 164.09
Last Price 159.16
1st Support Level 153.74
2nd Support Level 148.32
3rd Support Level 143.39

See More

52-Week High 228.88
Fibonacci 61.8% 176.54
Fibonacci 50% 160.37
Last Price 159.16
Fibonacci 38.2% 144.20
52-Week Low 91.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.